共 216 条
- [1] Harris A(2001)Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries Exp Rev Pharmacoecon Outcomes Res 1 7-357
- [2] Buxton M(2012)Similarities and differences between five European drug reimbursement systems Int J Technol Assess Health Care 28 349-S9
- [3] Orien B(2009)QALYs: the basics Value Health 12 S5-349
- [4] Drummond RF(2010)Is the EQ-5D fit for purpose in mental health? Br J Psychiatry 197 348-920
- [5] Drummond M(2011)How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review Value Health 14 907-394
- [6] Franken M(2010)Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders Br J Psychiatry 197 386-1236
- [7] le Polain M(2006)Comparison of EQ-5D and SF-6D utilities in mental health patients Health Econ 15 1229-243
- [8] Cleemput I(2014)Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D Br J Psychiatry 205 236-188
- [9] Koopmanschap M(2014)A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures Health Technol Assess 18 1-93
- [10] Weinstein MC(2014)Quality of life instruments for economic evaluations in health and social care for older people: a systematic review Soc Sci Med 102 83-20